| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/16/2007 | EP1265900B1 1,5-disubstituted-3,4-dihydro-1h-pyrimido 4,5-d|pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
| 05/16/2007 | EP1263347B1 System for the controlled delivery of an active material to a dental site |
| 05/16/2007 | EP1262181B1 Use of isothiazole derivatives as urease inhibitors for the treatment of helicobacter pylori induced gastrointestinal diseases |
| 05/16/2007 | EP1169340B1 Lantibiotic |
| 05/16/2007 | EP1129190B1 Human tslp dna and polypeptides |
| 05/16/2007 | EP0989853B1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 05/16/2007 | CN1964979A Novel water-soluble prodrug |
| 05/16/2007 | CN1964971A Amino-halogen-imidazopyridines as proton pump inhibitors |
| 05/16/2007 | CN1962874A Construction and use of Q-type human paraoxonase 1 gene expression vector |
| 05/16/2007 | CN1962693A Long-acting thymosin alpha1 polyethylene glycol modifier |
| 05/16/2007 | CN1962641A Metalloproteinase inhibitors |
| 05/16/2007 | CN1962615A Diamine compound for resisting hepatitis B virus and its preparation method and its application |
| 05/16/2007 | CN1962596A Ketone compounds and compositions for cholesterol management and related uses |
| 05/16/2007 | CN1961952A Medicament for promoting diuresis and diminishing inflammation and preparation process thereof |
| 05/16/2007 | CN1961935A Health-care liquid formulation for strengthening and preserving health |
| 05/16/2007 | CN1961929A 'Yi Kang Bu Yuan' formulation for benefiting qi, moving blood, invigorating spleen and tonifying kidney, its preparation method and quality control method |
| 05/16/2007 | CN1961907A Natural medicinal composition for preventing and treating liver disease |
| 05/16/2007 | CN1961897A Method for verifying pomegranate rind extract |
| 05/16/2007 | CN1961888A Lyophilized powder injection of baikal skullcap root extract and preparation method thereof |
| 05/16/2007 | CN1961886A Method for preparing Polyene Phosphatidylcholine injection liquid |
| 05/16/2007 | CN1961881A Pharmaceutical composition for treating or preventing respiratory and digestive diseases of birds and livestocks |
| 05/16/2007 | CN1961875A A liver-benefiting kidney-nourishing detoxifying dampness-removing medicament for treating hepatitis |
| 05/16/2007 | CN1961874A Pharmaceutical composition of Silybin and preparation method thereof |
| 05/16/2007 | CN1961869A Orally disintegrating tablet of coenzyme Q10 and preparation method thereof |
| 05/16/2007 | CN1961868A A rapidly disintegrating tablet of acid sensitive drug |
| 05/16/2007 | CN1961737A An instant pickled vegetables containing live probiotics and preparation method thereof |
| 05/16/2007 | CN1961725A Method for preparing health sheet jelly by use of hulless oat |
| 05/16/2007 | CN1961716A Nutrition digestion enhancer for fox |
| 05/16/2007 | CN1315862C Methods and compositions for treating flaviviruses and pestiviruses |
| 05/16/2007 | CN1315847C 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315813C 2-amino-4h-3,1-benzoxazin-4-one derivatives for the treatment of obesity |
| 05/16/2007 | CN1315535C Adjuvant for improving hepatitis B vaccine immune effect and preparing method thereof |
| 05/16/2007 | CN1315527C Externally used cold-evil expelling prepn |
| 05/16/2007 | CN1315518C Hepatic disease treating medicine |
| 05/16/2007 | CN1315504C Extract for treating functional indigestion and its medicine composition |
| 05/16/2007 | CN1315483C Compositions internal or relevant improvement |
| 05/16/2007 | CN1315479C Use of oleuropein in preparation of drug for inhibiting angiogenesis |
| 05/16/2007 | CN1315470C Compound liver-benefiting dropping pill for treating hepatitis and its preparing method |
| 05/16/2007 | CN1315469C Golden gallbladder-normalizing dropping pill for relaxing-liver and normalizing gallbladder, and its preparing method |
| 05/16/2007 | CN1315468C Liver-benefiting dropping pill prepared from total neterosides of swertia mileensis, and its preparing method |
| 05/16/2007 | CN1315467C liver-clearing dropping pill for treating hepatitis and its preparing method |
| 05/16/2007 | CN1315461C Jaundice capillaris drip pill and its preparation method |
| 05/16/2007 | CN1315460C Velvet deerhorn drip pill and its preparation method |
| 05/16/2007 | CN1315459C Compound lichen poria drip pill and its preparation method |
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217796 Neutralizing human anti-IGFR antibody |
| 05/15/2007 | US7217738 β2-adrenergic receptor agonists |
| 05/15/2007 | US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217724 2-[(2-hydroxy-2-pyridinylethyl)amino]ethyl-substituted indoles, e.g., N,N-Diethyl-2-{3-[(2R)-2-((2R)-2-hydroxy-2-pyridin-3-ylethylamino)-propyl]-1H-indol-7-yloxy}acetamide; beta 3-adrenoceptor stimulants, used for treating obesity, hyperglycemia, frequent urination, and urinary incontinence |
| 05/15/2007 | US7217719 1,3,8-Triaza-spiro[4.5]decan-2-one compounds, e.g., (4S)/(4R)-4-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-8-methyl-1,3,8-triaza-spiro [4.5]decan-2-one; treating schizophrenia, psychosis, migraine, hypertension, thrombosis, vasospasm, depression, anxiety, sleep and eating disorders |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/15/2007 | US7217701 Intracellular calcium concentration increase inhibitors |
| 05/15/2007 | US7217692 Complex of a human FOXC2 protein and a FOXC2-interacting protein |
| 05/15/2007 | US7217429 Preventing the drug breakdown due to abnormal secretion of gastric acid, coatings comprising non-alkaline water-soluble cellulose such as hydroxypropylmethyl cellulose or hydroxypropyl cellulose |
| 05/15/2007 | US7217414 Methods of preventing peritonitis by administering lactic acid bacterium |
| 05/15/2007 | CA2392973C Benzoimidazole derivatives useful as antiproliferative agents |
| 05/15/2007 | CA2366829C Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives |
| 05/15/2007 | CA2366186C Retinoid antagonists and use thereof |
| 05/15/2007 | CA2295087C Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 05/10/2007 | WO2007052837A1 Gastrointestinal function promoter |
| 05/10/2007 | WO2007052641A1 Intestinal immunity activator |
| 05/10/2007 | WO2007052629A1 Oligo double-stranded rna and pharmaceutical composition |
| 05/10/2007 | WO2007051845A1 Tricyclo substituted amides |
| 05/10/2007 | WO2007051463A2 Use of an activated zeolite as a pharmaceutical agent for reducing poisonous substances |
| 05/10/2007 | WO2007051408A1 Compounds for preventing or treating the h.pylori infection, preparation methods and use therrof |
| 05/10/2007 | WO2007007281A3 Muscarinic receptor antagonists |
| 05/10/2007 | WO2006111251A3 Hydro-alcoholic extract of butea frondosa flowers, a process for its preparation, pharmaceutical compositions containing it and its use for the treatment of ulcer |
| 05/10/2007 | WO2006105313A3 Compositions of and methods of using oversulfated glycosaminoglycans |
| 05/10/2007 | WO2006045298A3 Treatment of the consequences of alcohol abuse hepatitis pancreatitis |
| 05/10/2007 | US20070106076 Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino [1,2-a] indoles |
| 05/10/2007 | US20070105961 1-Amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists |
| 05/10/2007 | US20070105958 Compounds for the treatment of metabolic disorders |
| 05/10/2007 | US20070105949 Intermediates for the preparation of lipoxin A4 analogs |
| 05/10/2007 | US20070105936 new crystals forms of Sodium trans-4-[1-[2,5-dichloro-4-[(1-methyl-1H-3-indolylcarbonyl)amino]phenylacetyl]-(4S)-methoxy(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylate pentahydrate; VLA-4 (very late antigen-4) inhibitor; therapeutic drug for disorders caused by cell adhesion; water soluble, stability |
| 05/10/2007 | US20070105933 Amino alcohol compounds |
| 05/10/2007 | US20070105899 Benzene compounds |
| 05/10/2007 | US20070105897 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/10/2007 | US20070105889 Administering (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C) for therapy of disorders of the central nervous system; damage to the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus, and sleep apnea |
| 05/10/2007 | US20070105883 Novel physiologically active substances pf127oa, b and c substances |
| 05/10/2007 | US20070105860 Biphenylcarboxylic Amide Derivatives as p38 Kinase Inhibitors |
| 05/10/2007 | US20070105859 4-Phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (mek) inhibitors |
| 05/10/2007 | US20070105843 Combination of a serotonin reuptake inhibitor and a 5-ht2c antagonist, inverse agonist or partial agonist |
| 05/10/2007 | US20070105818 Water solubility, bioavailability, oral administration; unit dosage |
| 05/10/2007 | US20070105812 Treating HIV-1 viral infections by administering a phospholipid choline derivative, e.g., 1-dodecanamido-2-decyloxypropyl-3-phosphocholine |
| 05/10/2007 | US20070105785 Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators |
| 05/10/2007 | US20070105191 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 05/10/2007 | US20070104731 Helicobacter proteins and vaccines |
| 05/10/2007 | DE102006048362A1 Composition, useful to treat and/or protect disease condition e.g. circulatory disorder, comprises an active substance combination of isoflavone or isoflavone glycoside and a peptide derivative |
| 05/10/2007 | CA2784168A1 Growth control of oral and superficial microorganisms using gallium compounds |
| 05/10/2007 | CA2628414A1 Gastrointestinal function promoter |
| 05/10/2007 | CA2626475A1 Tricyclo substituted amides |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |